ANDREA SCHMITT

Índice h a partir de 2011
31
Projetos de Pesquisa
Unidades Organizacionais
LIM/27 - Laboratório de Neurociências, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 10 de 120
  • article 86 Citação(ões) na Scopus
    The role of the cerebellum in schizophrenia: from cognition to molecular pathways
    (2011) YEGANEH-DOOST, Peyman; GRUBER, Oliver; FALKAI, Peter; SCHMITT, Andrea
    Beside its role in motor coordination, the cerebellum is involved in cognitive function such as attention, working memory, verbal learning, and sensory discrimination. In schizophrenia, a disturbed prefronto-thalamo-cerebellar circuit has been proposed to play a role in the pathophysiology. In addition, a deficit in the glutamatergic N-methyl-D-aspartate (NMDA) receptor has been hypothesized. The risk gene neuregulin 1 may play a major role in this process. We demonstrated a higher expression of the NMDA receptor subunit 2D in the right cerebellar regions of schizophrenia patients, which may be a secondary upregulation due to a dysfunctional receptor. In contrast, the neuregulin 1 risk variant containing at least one C-allele was associated with decreased expression of NMDA receptor subunit 2C, leading to a dysfunction of the NMDA receptor, which in turn may lead to a dysfunction of the gamma amino butyric acid (GABA) system. Accordingly, from post-mortem studies, there is accumulating evidence that GABAergic signaling is decreased in the cerebellum of schizophrenia patients. As patients in these studies are treated with antipsychotics long term, we evaluated the effect of long-term haloperidol and clozapine treatment in an animal model. We showed that clozapine may be superior to haloperidol in restoring a deficit in NMDA receptor subunit 2C expression in the cerebellum. We discuss the molecular findings in the light of the role of the cerebellum in attention and cognitive deficits in schizophrenia.
  • article 4 Citação(ões) na Scopus
    Sex-dependent effects of long-term clozapine or haloperidol medication on red blood cells and liver iron metabolism in Sprague Dawley rats as a model of metabolic syndrome
    (2022) BOUVIER, Marie-Luise; FEHSEL, Karin; SCHMITT, Andrea; MEISENZAHL-LECHNER, Eva; GAEBEL, Wolfgang; WILMSDORFF, Martina von
    Background Patients with liver diseases often have some form of anemia. Hematological dyscrasias are known side effects of antipsychotic drug medication and the occurrence of agranulocytosis under clozapine is well described. However, the sex-dependent impact of clozapine and haloperidol on erythrocytes and symptoms like anemia, and its association with hepatic iron metabolism has not yet been completely clarified. Therefore, in the present study, we investigated the effect of both antipsychotic drugs on blood parameters and iron metabolism in the liver of male and female Sprague Dawley rats. Methods After puberty, rats were treated orally with haloperidol or clozapine for 12 weeks. Blood count parameters, serum ferritin, and liver transferrin bound iron were determined by automated counter. Hemosiderin (Fe3+) was detected in liver sections by Perl's Prussian blue staining. Liver hemoxygenase (HO-1), 5'aminolevulinate synthase (ALAS1), hepcidin, heme-regulated inhibitor (HRI), cytochrome P4501A1 (CYP1A1) and 1A2 (CYP1A2) were determined by Western blotting. Results We found anemia with decreased erythrocyte counts, associated with lower hemoglobin and hematocrit, in females with haloperidol treatment. Males with clozapine medication showed reduced hemoglobin and increased red cell distribution width (RDW) without changes in erythrocyte numbers. High levels of hepatic hemosiderin were found in the female clozapine and haloperidol medicated groups. Liver HRI was significantly elevated in male clozapine medicated rats. CYP1A2 was significantly reduced in clozapine medicated females. Conclusions The characteristics of anemia under haloperidol and clozapine medication depend on the administered antipsychotic drug and on sex. We suggest that anemia in rats under antipsychotic drug medication is a sign of an underlying liver injury induced by the drugs. Changing hepatic iron metabolism under clozapine and haloperidol may help to reduce these effects of liver diseases.
  • article 77 Citação(ões) na Scopus
    HDAC1 links early life stress to schizophrenia-like phenotypes
    (2017) BAHARI-JAVAN, Sanaz; VARBANOV, Hristo; HALDER, Rashi; BENITO, Eva; KAURANI, Lalit; BURKHARDT, Susanne; ANDERSON-SCHMIDT, Heike; ANGHELESCU, Ion; BUDDE, Monika; STILLING, Roman M.; COSTA, Joan; MEDINA, Juan; DIETRICH, Detlef E.; FIGGE, Christian; FOLKERTS, Here; GADE, Katrin; HEILBRONNER, Urs; KOLLER, Manfred; KONRAD, Carsten; NUSSBECK, Sara Y.; SCHERK, Harald; SPITZER, Carsten; STIERL, Sebastian; STOECKEL, Judith; THIEL, Andreas; HAGEN, Martin von; ZIMMERMANN, Joerg; ZITZELSBERGER, Antje; SCHULZ, Sybille; SCHMITT, Andrea; DELALLE, Ivana; FALKAI, Peter; SCHULZE, Thomas G.; DITYATEV, Alexander; SANANBENESI, Farahnaz; FISCHER, Andre
    Schizophrenia is a devastating disease that arises on the background of genetic predisposition and environmental risk factors, such as early life stress (ELS). In this study, we show that ELS-induced schizophrenia-like phenotypes in mice correlate with a widespread increase of histone-deacetylase 1 (Hdac1) expression that is linked to altered DNA methylation. Hdac1 overexpression in neurons of the medial prefrontal cortex, but not in the dorsal or ventral hippocampus, mimics schizophrenia-like phenotypes induced by ELS. Systemic administration of an HDAC inhibitor rescues the detrimental effects of ELS when applied after the manifestation of disease phenotypes. In addition to the hippocampus and prefrontal cortex, mice subjected to ELS exhibit increased Hdac1 expression in blood. Moreover, Hdac1 levels are increased in blood samples from patients with schizophrenia who had encountered ELS, compared with patients without ELS experience. Our data suggest that HDAC1 inhibition should be considered as a therapeutic approach to treat schizophrenia.
  • article 18 Citação(ões) na Scopus
    Reduction of gyrification index in the cerebellar vermis in schizophrenia: A post-mortem study
    (2011) SCHMITT, Andrea; SCHULENBERG, Wiebke; BERNSTEIN, Hans-Gert; STEINER, Johann; SCHNEIDER-AXMANN, Thomas; YEGANEH-DOOST, Peyman; MALCHOW, Berend; HASAN, Alkomiet; GRUBER, Oliver; BOGERTS, Bernhard; FALKAI, Peter
    Objectives. In schizophrenia, alterations of the gyrification index (GI) have been measured in cortical brain regions and are related to neurodevelopmental disturbances. Cerebellar regions have been implicated in the pathophysiolopgy of schizophrenia; however, the GI has not been investigated here so far. Methods. Hence, in a post-mortem study we investigated the GI separately from the vermis, left and right hemisphere of the medial posterior cerebellum in nine schizophrenia patients and 10 healthy controls. GI was defined as length of the inner contour inclusively depth of the sulci divided by length of the outer contour of the cerebellar surface and measured by tracing contours on images obtained by a stereological workstation. Results. In the vermis, GI was reduced in schizophrenia patients according to the methods of Zilles (P = 0.020) and Vogeley (P = 0.015). In the hemispheres, no differences have been observed. GI obtained by the two methods showed a high correlation (P < 0.001). Correlation analysis showed no influence of gender, postmortem interval and age. Conclusions. Decreased GI in the vermis of schizophrenia patients may result from neurodevelopmental disturbances, since folding of the brain occurs mainly during the perinatal period. MRI studies using automated GI processing in larger samples are needed to confirm our results.
  • article 0 Citação(ões) na Scopus
    New treatment strategies for mental health
    (2023) HASHIMOTO, Kenji; SCHMITT, Andrea
  • article 23 Citação(ões) na Scopus
    A systematic review of trials investigating strength training in schizophrenia spectrum disorders
    (2018) KELLER-VARADY, Katriona; VARADY, Patrick A.; ROEH, Astrid; SCHMITT, Andrea; FALKAI, Peter; HASAN, Alkomiet; MALCHOW, Berend
    This systematic review analyzed strength training (ST) in patients with schizophrenia. Two independent reviewers searched PubMed and CENTRAL. Only two studies reported on the effects of isolated ST. ST with a single exercise did not improve psychopathology but walking performance. ST for several large muscle groups significantly improved muscle strength and psychopathology. To date, no treatment recommendations can be made for ST. Consistent with recommendations for healthy people combined strength and endurance training can be recommended for schizophrenia. For higher transparency regarding trainings aspects, we recommend for future studies to use the sport science checklist proposed in this paper.
  • article 9 Citação(ões) na Scopus
    Association between altered hippocampal oligodendrocyte number and neuronal circuit structures in schizophrenia: a postmortem analysis
    (2020) FALKAI, Peter; RAABE, Florian; BOGERTS, Bernhard; SCHNEIDER-AXMANN, Thomas; MALCHOW, Berend; TATSCH, Laura; HUBER, Verena; SLAPAKOVA, Lenka; DOBROWOLNY, Henrik; SCHMITZ, Christoph; CANTUTI-CASTELVETRI, Ludovico; SIMONS, Mikael; STEINER, Johann; SCHMITT, Andrea
    In schizophrenia, decreased hippocampal volume, reduced oligodendrocyte numbers in hippocampal cornu ammonis (CA) subregions and reduced neuron number in the dentate gyrus have been reported; reduced oligodendrocyte numbers were significantly related to cognitive deficits. The hippocampus is involved in cognitive functions and connected to the hypothalamus, anterior thalamus, and cingulate cortex, forming the Papez circuit, and to the mediodorsal thalamus. The relationship between the volume of these interconnected regions and oligodendrocyte and neuron numbers in schizophrenia is unknown. Therefore, we used stepwise logistic regression with subsequent multivariate stepwise linear regression and bivariate correlation to analyze oligodendrocyte and neuron numbers in the posterior hippocampal subregions CA1, CA2/3, CA4, dentate gyrus, and subiculum and volumes of the hippocampal CA region, cingulum, anterior and mediodorsal thalamus and hypothalamus in postmortem brains of 10 schizophrenia patients and 11 age- and gender-matched healthy controls. Stepwise logistic regression identified the following predictors for diagnosis, in order of inclusion: (1) oligodendrocyte number in CA4, (2) hypothalamus volume, (3) oligodendrocyte number in CA2/3, and (4) mediodorsal thalamus volume. Subsequent stepwise linear regression analyses identified the following predictors: (1) for oligodendrocyte number in CA4: (a) oligodendrocyte number in CA2/3, (b) diagnostic group, (c) hypothalamus volume, and (d) neurons in posterior subiculum; (2) for hypothalamus volume: (a) mediodorsal thalamus volume; (3) for oligodendrocyte number in CA2/3: oligodendrocyte number (a) in posterior CA4 and (b) in posterior subiculum; (4) for mediodorsal thalamus volume: volumes of (a) anterior thalamus and (b) hippocampal CA. In conclusion, we found a positive relationship between hippocampal oligodendrocyte number and the volume of the hypothalamus, a brain region connected to the hippocampus, which is important for cognition.
  • article 10 Citação(ões) na Scopus
    Improvement in daily functioning after aerobic exercise training in schizophrenia is sustained after exercise cessation
    (2021) FALKAI, Peter; MAURUS, Isabel; SCHMITT, Andrea; MALCHOW, Berend; SCHNEIDER-AXMANN, Thomas; ROELL, Lukas; PAPIOL, Sergi; WOBROCK, Thomas; HASAN, Alkomiet; KEESER, Daniel
  • article 29 Citação(ões) na Scopus
    Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients
    (2012) SCHMITT, Andrea; LEONARDI-ESSMANN, Fernando; DURRENBERGER, Pascal F.; WICHERT, Sven P.; SPANAGEL, Rainer; ARZBERGER, Thomas; KRETZSCHMAR, Hans; ZINK, Mathias; HERRERA-MARSCHITZ, Mario; REYNOLDS, Richard; ROSSNER, Moritz J.; FALKAI, Peter; GEBICKE-HAERTER, Peter J.
    Inaccurate wiring and synaptic pathology appear to be major hallmarks of schizophrenia. A variety of gene products involved in synaptic neurotransmission and receptor signaling are differentially expressed in brains of schizophrenia patients. However, synaptic pathology may also develop by improper expression of intra- and extra-cellular structural elements weakening synaptic stability. Therefore, we have investigated transcription of these elements in the left superior temporal gyrus of 10 schizophrenia patients and 10 healthy controls by genome-wide microarrays (Illumina). Fourteen up-regulated and 22 downregulated genes encoding structural elements were chosen from the lists of differentially regulated genes for further qRT-PCR analysis. Almost all genes confirmed by this method were downregulated. Their gene products belonged to vesicle-associated proteins, that is, synaptotagmin 6 and syntaxin 12, to cytoskeletal proteins, like myosin 6, pleckstrin, or to proteins of the extracellular matrix, such as collagens, or laminin C3. Our results underline the pivotal roles of structural genes that control formation and stabilization of pre- and post-synaptic elements or influence axon guidance in schizophrenia. The glial origin of collagen or laminin highlights the close interrelationship between neurons and glial cells in establishment and maintenance of synaptic strength and plasticity. It is hypothesized that abnormal expression of these and related genes has a major impact on the pathophysiology of schizophrenia.
  • article 22 Citação(ões) na Scopus
    Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients
    (2017) CAFE-MENDES, C. C.; FERRO, E. S.; TORRAO, A. S.; CRUNFLI, F.; RIOLI, V.; SCHMITT, A.; FALKAI, P.; BRITTO, L. R.; TURCK, C. W.; MARTINS-DE-SOUZA, D.
    Schizophrenia is a complex disorder hypothesized to develop from a combination of genetic, neurodevelopmental, and environmental factors. Molecules that are directly involved in the pathogenesis of schizophrenia and may serve as biomarker candidates can be identified with ""omics"" approaches such as proteomics and peptidomics. In this context, we performed a peptidomic study in schizophrenia postmortem brains, to our knowledge the first such study in schizophrenia patients. We investigated the anterior temporal lobe (ATL) and corpus callosum (CC) by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) and a label-free ion quantification technique based on data-dependent acquisition (DDA). Results indicated alterations in a specific intracellular neurogranin peptide in both the ATL and CC and a decrease of PepH, a fragment of his tone H2B type 1-H intracellular peptide, in the ATL. PepH was tested in serum-deprived Neuro2A cells and showed a protective effect against cell death. Cells were also challenged with lipopolysaccharide (LPS), and PepH was able to prevent the endotoxic effects of LPS. Our data suggest that specific intracellular peptides are altered in schizophrenia patients. The potential biological activity of PepH supports intracellular peptides as novel targets in the study not only of schizophrenia but also of other neuropsychiatric diseases. Biological significance: Psychiatric disorders are considerably more difficult to diagnose in their early stages. Usually, by the time the diagnosis is clear and clinical treatment can be started, the disorder is already established and thus of greater severity. Consequently, the scientific community has been searching for biomarker candidates that can aid the early detection of such disorders and for novel therapeutics to improve treatment or at least delay disease progression. Moreover, key molecules involved in the establishment of psychiatric diseases may help the understanding of their pathogenesis and thus drive the development of more effective treatments. The present work screened peptides that might be possible novel targets to control cell machinery in schizophrenia and identified an intracellular peptide with potential cytoprotective activity. To our knowledge, this is the first peptidomic study in schizophrenia patients.